In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prescient Medical's Dual Approach to Vulnerable Plaque

Executive Summary

Vulnerable plaque caught investors' and entrepreneurs' attention several years ago as the mysterious cause of more than half of all cases of sudden cardiac death, most of which occurs in people with no history of heart disease. Several companies were launched and much money invested with little to show for it. One major problem: vulnerable plaque requires new tools both to diagnose and treat the condition, which proved to be bigger hurdles than most start-ups can overcome. Prescient was launched by an experienced device management team and is applying Raman spectroscopy, to coronary disease as the basis of its diagnostic tool, and is using a shield-not a stent-for its therapeutic device.
Advertisement

Related Content

Creating J&J's Cardiology Franchise: An Interview with Marv Woodall
InfraReDx: Saved by Angels (and a VC)
InfraReDx: Saved by Angels (and a VC)
Volcano's Second Act
Volcano Steps Up in Vulnerable Plaque By Buying Jomed's IVUS Business
Vulnerable Plaque: Medical Device's New Biological Frontier
Vulnerable Plaque: Medical Device's New Biological Frontier
Vulnerable Plaque Heats Up
Vulnerable Plaque Heats Up
The Unstable State of Plaque Detection

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003135

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel